Version chaos
Which draft did legal actually approve? The answer is usually somewhere in an email thread.
In development
RegulaAI
AI marketing governance for healthcare. Every asset reviewed against HIPAA, FDA, FTC, MHRA, EMA and country-level rulebooks in seconds, so your team moves quickly without carrying the legal risk.
Claims reviewPHI detectionFair balanceLocalizationApproval routingAudit trail
Early access
RegulaAI is not generally available yet. The working platform is live for preview and we are bringing teams in as capabilities open up.
The problem
Compliance review is where healthcare marketing waits
Every campaign, every market, every claim gets routed through legal and medical review and back again. Launches stall while competitors move, and two reviewers looking at the same asset can still reach two different answers with no record of why.
The exposure compounds. One unsupported claim carried across thirty markets is thirty exposures, not one. Generic copy checkers cannot help here, because they do not know what a claim means in healthcare, or that the same asset can be compliant for a physician audience and non-compliant for a patient one.
RegulaAI sits between the marketing team and the regulator. It catches the issue, proposes the fix, and keeps a defensible record of every decision made along the way.
What teams struggle with
Six problems every regulated marketing team knows by heart
Channel blind spots
Email, web, social, and sales decks each carry different rules, and a single review rarely covers all four.
Global rollouts
Localizing a campaign means re-reviewing it in every market it lands in.
Audit exposure
Reconstructing who approved what, months later, from records that were never designed to be reconstructed.
Reviewer overload
A handful of experts gate the entire pipeline, and the pipeline does not slow down to match them.
Shadow risk
Assets ship without review because the queue was too slow to wait for.
How it works
From draft to approved, without the back and forth
One asset through the platform, every step automated and every decision recorded.
Upload or connect
Drop an asset, paste a URL, or pull it straight from the systems where your marketing already lives.
AI reviews instantly
Claims, protected health information, and disclosure gaps checked against every rule that applies to that audience, channel, and market.
Fix in line
Accept a suggested edit or rewrite it with the reviewer's reasoning next to you, rather than in a separate document.
Route and publish
Flagged items go to legal or medical with full context attached, and the approved asset ships with its audit record intact.
Your AI review team
Specialized reviewers for every layer of healthcare risk
Not one model guessing at everything, but a panel of focused reviewers, each responsible for a single domain of risk.
Claims analyst
Flags unsupported efficacy, safety, and comparative claims, then suggests language the substantiation actually supports.
Privacy guardian
Detects protected health information exposure and HIPAA or GDPR targeting violations before an asset reaches an audience.
Disclosure checker
Verifies fair balance, important safety information, and required disclaimers are present and prominent enough to count.
Regional specialist
Applies country-specific advertising rules to every localized version, so one campaign is not thirty separate reviews.
Brand and tone
Keeps language on brand and matched to the audience, because an asset compliant for an HCP may not be compliant for a patient.
Audit scribe
Records the rationale behind every flag, so a decision made today is still defensible when a regulator asks in two years.
Why healthcare is different
The rules change by audience, channel, and country
Healthcare marketing lives under overlapping medical, privacy, and advertising law. A general-purpose content checker has no way to hold all of it at once.
- Efficacy, safety, and comparative claims each carry their own substantiation bar.
- HIPAA and GDPR govern what you can show, store, and target, not just what you can say.
- Patient, clinician, and payer audiences change what compliant looks like for the same asset.
- FDA, FTC, MHRA, EMA, TGA and dozens more, each with living guidance that keeps moving.
0s
target review time per asset
0+
country rulebooks in scope
0+
regulators including FDA, FTC, MHRA, EMA
0%
of flags logged with rationale and timestamp
Design targets for RegulaAI, not audited customer results. We publish measured outcomes as deployments produce them.
Built for your industry
Tuned to the rules of your corner of healthcare
Pharma and biotech
Promotional claims, fair balance, important safety information, off-label risk.
Medtech and devices
Intended-use language, clearance against approval, comparative claims.
Hospitals and health systems
Patient privacy, outcome claims, service line marketing.
Agencies
Multi-client governance, brand-safe delivery, audit-ready handoffs.
Visit the product site
RegulaAI has its own home, with the full platform walkthrough.
See RegulaAI review your own assets
Book a walkthrough and watch it review a real campaign, flags, suggested fixes, and audit trail included.